Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Rating of “Hold” from Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $5.64.

A number of brokerages have recently commented on DH. Deutsche Bank Aktiengesellschaft lowered their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Stifel Nicolaus decreased their target price on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. Canaccord Genuity Group decreased their target price on Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Wednesday, May 8th. Robert W. Baird decreased their target price on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Tuesday, August 6th.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.69 on Monday. The company has a market cap of $553.12 million, a P/E ratio of -2.68, a P/E/G ratio of 6.78 and a beta of 1.30. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The stock has a 50-day moving average of $4.87 and a two-hundred day moving average of $6.34. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The company had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. Definitive Healthcare’s revenue was up 4.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.08 EPS. As a group, analysts anticipate that Definitive Healthcare will post 0.08 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of DH. Millennium Management LLC acquired a new stake in Definitive Healthcare in the second quarter valued at $9,283,000. Massachusetts Financial Services Co. MA grew its holdings in Definitive Healthcare by 76.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,466,514 shares of the company’s stock valued at $34,457,000 after purchasing an additional 1,496,652 shares during the last quarter. 272 Capital LP acquired a new stake in Definitive Healthcare in the second quarter valued at $3,480,000. Marshall Wace LLP acquired a new stake in Definitive Healthcare in the second quarter valued at $1,535,000. Finally, Raymond James & Associates grew its holdings in Definitive Healthcare by 41.6% in the first quarter. Raymond James & Associates now owns 844,814 shares of the company’s stock valued at $6,818,000 after purchasing an additional 248,266 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.